US biotech firm Moderna on Monday announced its experimental vaccine against Covid-19 was 94.5 percent effective, marking a second major breakthrough in the vaccine hunt.

WION Dispatch: Moderna says its COVID-19 vaccine is over 94% effective

A lead scientist behind Pfizer's coronavirus vaccine, Ugur Sahin, has warned that the jab needs time to be effective and that life will not return to normal till next winter.

Lead scientist behind Pfizer's COVID-19 vaccine, Ugur Sahin, says life will not return to normal till next winter

Positive data on BioNTech and US partner Pfizer Inc's COVID-19 vaccine came as a happy surprise for not only the world, but also the married couple behind the German biotech firm. Physicians Ugur Sahin and Oezlem Tuereci, who bonded over their love of medical research, are the people behind the Covid-19 vaccine that could change the world.

Who is the couple behind Pfizer's COVID vaccine that could change the world?

After Pfizer's claim that the COVID-19 vaccine is more than 90% effective based on initial trial results, a few volunteers said that they suffered side effects comparable to a flu jab, with one comparing them to "a severe hangover".

Volunteers face 'severe hangover', headache and pain after getting Pfizer vaccine shot

The entire world is scrambling to formulate a potion for the coronavirus-ravaged human race -- a Covid-19 vaccine. And scientists have been successful too. But the vaccines have unfortunately exhibited a few side-effects -- proving to be a setback for humanity and its survival in the face of the raging coronavirus pandemic.

Where are we in the COVID-19 vaccine race? Here's a status check of trials and side-effects

India is racing ahead with work on its coronavirus vaccine as countries around the world sought to conquer the pandemic and rescue their economies. Also read | Volunteers face 'severe hangover', headache and pain after getting Pfizer vaccine shot Companies like Zydus Cadila, Serum Institute and Bharat Biotech are at the forefront of research on covid vaccines and are likely to be among the leading manufacturers as and when their commercial application is permitted.

These three Indian companies are ready to produce Covid-19 vaccine

China on Monday denied that one of its naval vessels shone a laser at Australian military aircraft. The incident was termed an 'act of intimidation' by Australian Prime Minister Scott Morrison.

Watch: Russia's COVID-19 vaccine Sputnik V arrives in India

Pfizer Inc is currently in discussions with the government to distribute its potential COVID-19 vaccine in India. "We remain committed to advance our dialogue with the Government of India to make this vaccine available for use in the country," Indian media quoted the spokesperson as saying.

Pfizer in talks with government to bring its COVID-19 vaccine to India: Report

Serum Insitute of India, the world's largest maker of vaccines, on Thursday said it has already produced 40 million doses of AstraZeneca's potential COVID-19 vaccine.

India's Serum Institute, world's largest vaccine maker says 40 million doses of AstraZeneca drug produced

Stock markets gained on Wednesday, as news of a working COVID-19 vaccine seemed to inoculate investors against worry about surging infections in Europe and the United States, while the kiwi rose as traders thought the central bank sounded upbeat.

Global stocks up as vaccine shields against second-wave worries

News of a breakthrough in the race to find a COVID-19 vaccine sparked one of the heaviest trading days since the height of the pandemic crisis, according to early data analysed by Reuters, with nearly $2 trillion (1.51 trillion pounds) changing hands on Monday.

Nearly $2 trillion traded on COVID-19 vaccine news

The trial of a Chinese vaccine has been suspended in Brazil after a 'serious adverse event'. China is not the only player in the vaccine race. WION's Palki Sharma tells you more about the candidates in the global vaccine hunt.

Gravitas: Chinese vaccine triggers 'serious adverse event',  Brazil suspends trials

India: Sensex trading above 43,500 mark

The experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE may not be coming to local pharmacies for the general public any time soon. The vaccine's complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon

US President Donald Trump on Monday accused the Food and Drug Administration (FDA) and Pfizer of withholding the announcement on the COVID-19 vaccine before elections to prevent him from getting a "vaccine win".

Trump accuses FDA and Pfizer of withholding COVID-19 vaccine announcement before elections

Demand for COVID-19 antiviral drug Remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.

Indian demand for COVID-19 drug Remdesivir rising sharply: Cipla

Bangladesh has signed a crucial deal with the Serum Institute of India to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for COVID-19.

COVID-19 vaccine: Bangladesh signs deal with Serum Institute of India

India on Friday briefed 190 heads of the diplomatic mission and international organisations for two hours on its covid related measures including on vaccine development.

Foreign envoys welcome MEA's COVID briefing; India to show its vaccine facility

According to reports, India's Covaxin vaccine for the Wuhan Virus could be ready by February next year. Palki Sharma Upadhyay tells you what this means for India's fight against the pandemic.

Gravitas: Wuhan Coronavirus: India to get a vaccine in February?

According to reports, India's Covaxin vaccine for the Coronavirus could be ready by February next year. The question of course is how safe is this? WION brings you a report.

India made Coronavirus vaccine to be ready by February?

Bangladesh signed a deal with the Serum Institute of India on Thursday to buy 30 million doses of potential coronavirus vaccine being developed by British drugmaker AstraZeneca.

Bangladesh signs deal with India for 30 million doses of COVID-19 vaccine

Moderna has said that it is on track to report early data from a late stage trial of it's experimental COVID-19 vaccine as early as next month. Watch the report to know more.

Moderna preparing to launch covid-19 vaccine

India's vaccine production and delivery capacity will be used to help all humanity in fighting the COVID-19 pandemic, and it will also help countries in enhancing their cold chain and storage capacities, the Ministry of External Affairs said on Thursday.

India's vaccine production, delivery capacity to help all humanity in fighting COVID-19: MEA

Drugmaker Dr Reddy's Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia's coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.

India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's

covid-19-vaccine

Covid 19 Vaccine, News on Covid 19 Vaccine, stories on Covid 19 Vaccine, articles on Covid 19 Vaccine, Covid 19 Vaccine stories at Wion, Covid 19 Vaccine news, Covid 19 Vaccine latest news

covid 19-vaccine